19 Jun, 2013
The Leela Palace, Bengaluru
Home >> M & A >>
Tuesday, July 3, 2012 - 18:48 IST
Poonawalla’s Serum Institute buys NVI’s production biz for $40M
BY Megha Arora
Serum had earlier acquired a stake in Lipoxen PLC, a biopharmaceutical company, for around $ 4.9 million in 2006.
The Serum Institute of India Limited (Serum) has acquired the production unit of Netherland’s state-owned vaccine maker Netherlands Vaccine Institute (NVI) called Bilthoven Biologicals for €32 million ($40 million). The manufacturing activities of the NVI have been making losses...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Private Equity - Nereus Capital
- Associate - Red Fort Capital Advisors Pvt Ltd
RECENT COMMENTS
- 17 June 2013rj.sridhar@gmail.comonI think it's a bit of a chicken & egg. Is it the combination of some shady promoters plus lack of enough exits...
- 16 June 2013Raj BhattonGoing by the numbers, this values Snowman at 21.7X Mar'13 earnings and 3.5X assets. It is a brilliant pre-IPO...
- 15 June 2013sharad_dalal@hotmail.comonI think this article paints a very distorted picture of a typical PE term sheet. Investment in the form of...
- 14 June 2013SummeeronA candid article Pravin. The situation is indeed piquant. In good companies, where funds fall over each other for the...
UPCOMING EVENTSchinetwork